0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight septic shock global api manufacturers marketed phase iii drugs landscape 2015.Your search for "" gave back 1533063 results.
Inclusion Body Myositis (IBM) - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
October 2020
Price: USD 2,000.00
Inclusion Body Myositis (IBM) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
April 2020
Price: USD 2,000.00
Polycythemia Vera - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
August 2018
Price: USD 2,000.00
Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest...
Catalog:
Global Markets Direct
April 2022
Price: USD 2,500.00
Melanocyte Stimulating Hormone Receptor - Drugs In Development, 2021 Summary Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
Sedation - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sedation -...
Catalog:
Global Markets Direct
August 2019
Price: USD 2,000.00
The global Sepsis Treatment Drugs market is projected to reach US$ 5571.7 million in 2029, increasing from US$ 3449.4 million in 2022, with the CAGR...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Familial Adenomatous Polyposis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
February 2018
Price: USD 2,000.00
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H2 2018 Summary Fibroblast...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
The global Sepsis Treatment Drugs market was valued at US$ 3449.4 million in 2023 and is anticipated to reach US$ 5571.7 million by 2030, witnessing...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Summary Publisher estimates that the Acute Lymphocytic and Lymphoblastic Leukemia Therapeutics market size will grow from xxx Million USD in 2020 to...
Catalog:
HYR
May 2021
Price: USD 2,000.00
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020 Summary 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - The 5-HT6...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Summary The Acute Lymphocytic and Lymphoblastic Leukemia Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Interleukin 1 - Pipeline Review, H2 2020 Summary Interleukin 1 (IL1) pipeline Target constitutes close to 30 molecules. Out of which approximately 29...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
Birch Pollen Allergy (Immunology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
March 2021
Price: USD 2,000.00
